Clinical trial
Effect of Cannabinoids on Pain in Fabry Disease Patients; a Prospective, Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study
NCT04820361 is registered in ClinicalTrials.gov with Albina Nowak, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cannabinoids on Pain in Fabry Disease Patients; a Prospective, Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study
- Lead sponsor
- Albina Nowak, MD
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 7, 2022
- Completion date
- December 29, 2023
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, neuropathic